Investors

#TitleYearAction
1Financial Statements2021-22 View
2Financial Statements2022-23 View
3Financial Statements2023-24 View
4Financial Statements2024-25 View
#TitleYearAction
1Financial Statements2021-22 View
2Financial Statements2022-23 View
3Financial Statements2023-24 View
4Financial Statements2024-25 View
#TitleYearAction
1Q2- Financial Statements- 30.09.20252025-26 View
2Q3- Financial Statements- 31.12.20252025-26 View
#TitleYearAction
1Annual Return-2024-252024-25 View
#TitleYearAction
1SHP- 31-03-20262025-26 View
#TitleYearAction
1ANNUAL REPORT 2024-252024-25 View
#TitleYearAction
1Investor Meet Intimation-11-03-20262025-26 View
2Investor Meet Intimation-02-12-20252025-26 View
3Investor Meet Intimation-01-12-20252025-26 View
4Investor Meet Intimation-16-12-20252025-26 View
5Investor Meet Intimation-25-02-20262025-26 View
6Investor Meet Intimation-24-08-20252025-26 View
7Investor Meet Intimation-22-09-20252025-26 View
8Investor Meet Intimation-03-10-20252025-26 View
9Investor Meet Intimation-29-11-20252025-26 View
#TitleYearAction
1Outcome of Investors’ Meeting-11-03-20262025-26 View
2Outcome of investor meet -29-11-20252025-26 View
3Outcome of Investors’ Meeting-03-10-20252025-26 View
4Outcome of Investors’ Meeting-22-09-20252025-26 View
5Outcome of Investors’ Meeting-23-09-20252025-26 View
6Outcome of Investors’ Meeting-02-12-20252025-26 View
7Outcome of Investors’ Meeting-01-12-20252025-26 View
8Outcome of Investors’ Meeting-16-12-20252025-26 View
9Outcome of Investors’ Meeting-25-02-20262025-26 View
#TitleYearAction
1Concall Transcripts-17-11-20252025-26 View
2Post Earnings Concall Intimation 16-02-20262025-26 View
3Concall Transcripts-16-12-20262025-26 View
4Concall Transcripts-16-12-20262025-26 View
#TitleYearAction
1Investor Presentation-17-11-20252025-26 View
2Investor Presentation for the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2025.2025-26 View
3Investor Presentation-24-08-20252025-26 View
#TitleYearAction
1Certificate Deviation Report-31-03-20252024-25 View
2Structured Digital Database (SDD) Compliance Certificate- 30-06-20252025-26 View
3Structured Digital Database (SDD) Compliance Certificate- 31-03-20252024-25 View
4Change in CIN (Post Listing)2025-26 View
5Financials- Press Release-31-03-20252024-25 View
6Integrated Corporate Governance Report for the Quarter Ended December 31, 20252025-26 View
7Corporate Governance Report (Q3) - Integrated Governance-31-12-20252025-26 View
8Statement of Investor Complaints for the Quarter ended 31st March, 20252024-25 View
9NSE Disclosure-25-09-25 Regulation 7(2)2025-26 View
10Reconciliation of Share Capital-30-06-20252025-26 View
11Certificate under Regulation 7(3) of the SEBI (LODR) Regulations, 20152025-26 View
12Non-Applicability of Regulation 27(2) of SEBI (LODR) Regulation, 2015 View
13Regulation 29 Prior intimation BM Approval of accounts 31-03-20252024-25 View
14Certificate as per Regulation 40(9) and (10) of the SEBI (LODR) Regulations, 2015 ("Listing Regulations") for the F.Y. ended on March 31, 20252024-25 View
15Regulation 76 -Reconciliation of Share Capital 31-03-20252024-25 View
16RTA Details View
17Declaration under Regulation 31(4) read with Regulation 31(5) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.2024-25 View
18Structured Digital Database (SDD) Compliance Certificate SEBI (PIT) Regulations, 2015 for the quarter ended September 30, 20252025-26 View
19SHP- 31-12-20252025-26 View
20SHP- 31-03-20252024-25 View
21Statement of Deviation 31-03-20252025-26 View
22Declaration under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.2025-26 View
#TitleYearAction
1Closure of Trading Window-31-03-20262025-26 View
2Closure of Trading Window-31-12-20252025-26 View
#TitleYearAction
1CODE OF BUSINESS CONDUCT AND ETHICS View
#TitleYearAction
1Insider Trading Policy View
#TitleYearAction
1Archival Policy View
2Board Diversity Policy View
3Insider Trading Policy View
4Code of Conduct View
5UPSI Policy View
6Corporate Governance View
7Criteria / Policy of Making Payments to Non-Executive Directors View
8CSR Policy View
9Familiarisation Programme View
10Materiality Policy View
11Nomination and Remuneration Policy View
12Policy And Procedure for Inquiry in Case of Leak or Suspected View
13Related Party Transaction Policy View
14Policy on Preservation of Documents View
15Policy on Sexual Harassment View
16Policy on Material events View
17Risk Assessment and Management Policy View
18Terms and conditions of Appointement of I D View
19Vigil Mechanism & Whistle Blower Policy View
20Vigil Mechanism & Whistle Blower Policy View
21POLICY ON MATERIAL SUBSIDIARIES View
22Dividend Distribution Policy View
#TitleYearAction
1Financial Statements- Chandan Pharmacy Limited2021-22 View
2Financial Statements- Chandan Pharmacy Limited2022-23 View
3Financial Statements- Chandan Pharmacy Limited2023-24 View
4Financial Statements- Chandan Pharmacy Limited2024-25 View
#TitleYearAction
1Financial Statements- Chandan Diagnostic Limited2021-22 View
2Financial Statements- Chandan Pharmacy Limited2022-23 View
3Financial Statements- Chandan Diagnostic Limited2023-24 View
4Financial Statements- Chandan Diagnostic Limited2024-25 View
5Financial Statements- Indra Diagnostic Centre & Blood Bank Limited2021-22 View
6Financial Statements- Indra Diagnostic Centre & Blood Bank Limited2022-23 View
7Financial Statements- Indra Diagnostic Centre & Blood Bank Limited2023-24 View
8Financial Statements- Indra Diagnostic Centre & Blood Bank Limited2024-25 View
#TitleYearAction
1List of Subsidiaries of Chandan Healthcare Limited View
#TitleYearAction
1Opening of a Diagnostic Centre in Ashiyana, Lucknow2025-26 View
2Opening of a Diagnostic Centre in Bhopal Madhya Pradesh2025-26 View
3Commencement of diagnostic operations in Kurukshetra, Haryana2025-26 View
4Commencement of Diagnostic Operations Kolkata2025-26 View
5Commencement of Diagnostic Operations in Mumbai2025-26 View
6Commencement of Diagnostic Operations in Kota, Rajasthan2025-26 View
7CRISIL Credit Rating-10-05-20252025-26 View
8Acquiring of X Life Diagnostics and Research Centre, Patna2024-25 View
9Investor Presentation-21-8-20252025-26 View
10Launch of Diagnostic Centre in Raipur Chhattisgarh2025-26 View
11Launch of Chandan Medical Centres2025-26 View
12Commencement of Diagnostic Operations at Mumbai, Maharashtra2025-26 View
13Opening of new Diagnostic Centre at Ayodhya, Uttar Pradesh2025-26 View
14Outcome of Investor Meeting held on October 3, 20252025-26 View
15Strategic Partnership with Jeena Sikho Lifecare Limited2025-26 View
16opening of new Diagnostic Centre at Prashant Vihar, New Delhi2025-26 View
17Commencement of diagnostic operations at Dera Bassi, Chandigarh, Punjab2025-26 View
18Submission of Earnings Release for the Quarter and Nine Months ended December 31, 20252025-26 View
19Investor Meeting-24-08-20252025-26 View
20Receipt of Award-Zee Dare to Dream2025-26 View
21Regulation 30-Schedule of meet - 22-09-20252025-26 View
22Schedule of meet 03-10-20252025-26 View
23Schedule of meet-17-09-20252025-26 View
24Revision-Award of PPP in Assam & Punjab2025-26 View
25Schedule of Post Earnings Conference Call for analysts and investors for H1 FY26 financial results2025-26 View
26Outcome of Board Meeting-27.03.20252024-25 View
2710-year PPP project by the Punjab Health Systems Corporation-02-03-20262025-26 View
28Tender for installation of a 1.5 Tesla MRI system at Civil Hospital, Rohtak (Haryana)-24-03-20262025-26 View
29Outcome of Board Meeting-Loan from Axis Bank-31-12-20252025-26 View
30Award of Public Private Partnership (PPP) Project in Punjab-13-12-20252025-26 View
#TitleYearAction
1Article of Association View
2Memorandum of Association View
3Management Team Information View
4Certificate of Incorporation2003-04 View
5Certificate of Registration of Regional Director order for Change of State2016-17 View
6Certificate of Registration of Regional Director order for Change of State2023-24 View
7Certificate of Registration of Regional Director order for Change of State2023-24 View
8Certificate of Registration of Regional Director order for Change of State2023-24 View
9Constitution of Committees View
10Director's Profile View
#TitleYearAction
1Article of Association View
2Red Herring Prospectus View
3Draft Red Herring Prospectus View
4List of Material Creditors View
5NSE In-principle Approval View
6Prospectus View
7Board Resolution for Approval of Draft Red Herring Prospectus (DRHP) View
8Board Resolution for Approval of Red Herring Prospectus (RHP) View
9Board Resolution for Approval of Prospectus View
10Consent from Banker to the offer-29-01-20252024-25 View
11Consent from Book Running Lead Manager-25-09-20242024-25 View
12Consent from CFO-26-08-20242024-25 View
13Consent from Compliance Officer & Company Secretary-26-08-20242024-25 View
14Consent from Directors-26-08-20242024-25 View
15Consent from RTA-10-09-20242024-25 View
16Consent from Selling Shareholders-28-08-20242024-25 View
17Consent Letter from Legal Counsel-20-09-20242024-25 View
18Consents from Promoters-28-08-20242024-25 View
#TitleYearAction
1Certificate from Statutory Auditor in terms of Regulation 169(5) of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 (“ICDR Regulations)-03-02-20262025-26 View
2PCS Certificate confirming compliance with Chapter V of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, for the proposed Preferential Issue of Fully Convertible Equity Warrants2025-26 View
3Outcome of Board meeting held 10-10-20252025-26 View
4Valuation Report on fair value of Equity Shares of Chandan Healthcare Limited as of October 06, 20252025-26 View
5Outcome of Preferential Issue Committee2025-26 View
6Intimation of Board Meeting under Regulation 29 of SEBI (LODR) Regulations, 20152025-26 View
7In principle Approval NSE-23-01-20262025-26 View
#TitleYearAction
1CDSL TPA-25-09-20242024-25 View
2Market Making Agreement-31-01-20252024-25 View
3NSDL-TPA-02-09-20242024-25 View
4Offer Agreement-28-09-20242024-25 View
5Public offer Account and Sponsor Bank Agreement-31-01-20252024-25 View
6RTA Agreement-11-09-20242024-25 View
7Share Escrow Agreement-31-01-20252024-25 View
8Syndicate Agreement-31-01-20252024-25 View
9Underwriting Agreement-31-01-20252024-25 View
#TitleYearAction
1Investor Grievance View
#TitleYearAction
1Transcript of 22nd Annual General Meeting-29-09-20252025-26 View
2Voting Results and Scrutinizer’s Report-29-09-20252025-26 View
3Proceedings of AGM-29-09-20252025-26 View
4Notice of AGM-29-09-20252025-26 View
5CORRIGENDUM TO THE NOTICE OF AGM-29-09-20252025-26 View
#TitleYearAction
1Proceedings of EGM-6-11-20252025-26 View
2Voting Results and Scrutinizer’s Report-06-11-20252025-26 View
3EGM Script-06-11-20252025-26 View
4Notice of EGM held on 06-11-20252025-26 View
5CORRIGENDUM TO THE NOTICE OF EGM-06-11-20252025-26 View


Welcome to the Investors page of Chandan Diagnostic, where transparency and accountability are at the forefront of our engagement with investors. As a leading provider of diagnostic services, we understand the importance of fostering trust and providing our investors with the information they need to make informed decisions.

Here, we invite you to connect with us to gain access to relevant details and insights that showcase our financial performance, growth strategies, and vision for the future. Whether you're a current investor, potential shareholder, or financial analyst, we're committed to providing you with the transparency and clarity you seek.

By connecting with us, you'll have the opportunity to engage directly with our investor relations team and gain deeper insights into our business operations, financial metrics, and strategic initiatives. Whether you have questions about our revenue streams, profitability margins, or growth prospects, we're here to provide you with the information and support you need.

Our investor relations team is dedicated to ensuring that you have access to timely and accurate information, enabling you to make informed investment decisions. Whether you prefer to connect via email, phone, or arrange a meeting, we're here to accommodate your needs and provide the information you seek.

Connect with us today to unlock the relevant details and insights you need to evaluate Chandan Diagnostic as an investment opportunity. We welcome the opportunity to engage with you, address your inquiries, and provide the information you need to confidently consider investing in our company.

Thank you for your interest in Chandan Diagnostic. We look forward to connecting with you and building a strong and transparent relationship with our investors.


Corporate Governance at Chandan Diagnostic: Upholding Excellence and Integrity

At Chandan Diagnostic, we hold ourselves to the highest standards of corporate governance, recognizing its fundamental importance in sustaining trust, transparency, and accountability across all facets of our operations. Our commitment to excellence and integrity is evident in every aspect of our corporate governance framework, which serves as the cornerstone of our organizational ethos.

Key Principles of Corporate Governance

  • Transparency: We believe in fostering transparency by providing clear, accurate, and timely information to all stakeholders. From financial reporting to strategic initiatives, we strive to maintain open communication channels that promote trust and confidence in our organization.
  • Accountability: We uphold accountability by establishing clear lines of responsibility and ensuring that decision-makers are held accountable for their actions. Our governance structure includes checks and balances that promote oversight and accountability at all levels of the organization.
  • Integrity: Integrity is the foundation of our corporate governance framework. We adhere to the highest ethical standards in all our interactions, conducting business with honesty, fairness, and integrity. Our commitment to integrity extends to our relationships with customers, employees, suppliers, and the broader community.
  • Ethical Leadership: Our leadership team sets the tone for ethical conduct within the organization. We promote a culture of integrity and ethical behavior, encouraging our leaders to lead by example and uphold the highest standards of professionalism and integrity in their decision-making.
  • Board Independence: The independence of our board of directors is essential to effective corporate governance. We maintain a diverse and independent board composed of experienced professionals who provide impartial oversight and guidance to ensure the interests of shareholders are protected.

Corporate Governance Practices at Chandan Diagnostic

  • Board of Directors: Our board of directors plays a pivotal role in overseeing the strategic direction and performance of the organization. Comprised of experienced professionals from diverse backgrounds, our board provides independent oversight and guidance to management, ensuring alignment with shareholder interests and corporate values.
  • Code of Conduct and Ethics: We have implemented a comprehensive Code of Conduct and Ethics that outlines the principles and standards of behavior expected from all employees, directors, and stakeholders. Our Code of Conduct reflects our commitment to integrity, honesty, respect, and ethical conduct in all business activities.
  • Risk Management: We maintain robust risk management processes to identify, assess, and mitigate risks that may impact our business operations or financial performance. Our risk management framework includes regular risk assessments, internal controls, and contingency plans to address potential risks effectively.
  • Internal Controls: We have established internal control mechanisms to safeguard our assets, ensure compliance with laws and regulations, and maintain the integrity of our financial reporting. Our internal control framework includes policies, procedures, and monitoring mechanisms to promote accountability and transparency.
  • Stakeholder Engagement: We value the input and feedback of our stakeholders and actively engage with them to understand their concerns, address their needs, and build trust and confidence in our organization. We maintain open channels of communication with shareholders, employees, customers, suppliers, and the broader community to foster dialogue and collaboration.

At Chandan Diagnostic, corporate governance is not just a regulatory requirement; it is a fundamental aspect of our corporate culture and identity. We are committed to upholding the highest standards of governance, guided by principles of transparency, accountability, integrity, and ethical leadership. Through our governance practices, we aim to build trust, foster sustainability, and create long-term value for all our stakeholders.


Book Diagnostic Centre
Book Test
Get Report Online
Get Report
Find Center Near Me
Find Center